Updated: Jun 19, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
Allison M Quick1, Simon S Lo, Nina A Mayr
1Department of Radiation Oncology, Arthur G James Cancer Hospital, Ohio State University Medical Center, 300 West 10th Avenue, Ste 088A, Columbus, OH 43210, USA. allison.quick@osumc.edu
Radiation therapy is now a viable option for liver cancers like hepatocellular carcinoma and metastasis, thanks to advanced techniques improving liver tolerance and treatment outcomes.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: